Notizie

Global consumers’ everyday lives are shaped by Swiss products and services at different levels and in various aspects. Our experts dive into the secret behind “Swiss-made” quality.

Le Temps (27.12.2021) - One fact about the financial industry that everyone agrees on nowadays is that, as a strategic allocator of private capital, it has a major role to play in reducing economies’ carbon footprint, and this is clear to see in the sharp growth of so-called “sustainable” funds.

The surge in inflation in 2021 combined with the sharp fall in unemployment leaves two of the US Federal Reserve’s key policy objectives within reach as the year comes to a close.

UBP annuncia oggi un importante progresso nell’impegno negli investimenti a impatto con il lancio di una strategia incentrata sulla biodiversità, una collaborazione unica tra i settori finanziario, aziendale e della conservazione.

The global pandemic has allowed the European Union to lay a new foundation upon which it can build to bring about greater integration in the years ahead.

As part of Building Bridges Week – the agenda-setting event on sustainable finance taking place in Geneva from 29 November to 2 December 2021 – UBP hosted an interactive panel discussion on biodiversity and its investment opportunities.

The Swiss small- and mid-cap (also known as “SMID-cap”) universe offers a balanced and diversified exposure to companies with long-term value-creation potential. Active managers can create significant added value through a disciplined stock-selection process.

Funds People (17.11.2021) - L'ascesa della gestione passiva, la difficoltà di trovare investimenti redditizi e a basso rischio in un contesto di tassi a zero, la concentrazione del settore o il boom degli ESG sono solo alcune delle sfide che i gestori si trovano ad affrontare. Di questo e altro abbiamo parlato con Nicolas Faller, Co-CEO AM Union Bancaire Privée.

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

Embracing Change

La Regione (29.11.2021) - L’anno che sta per chiudersi è stato caratterizzato oltre che dalla persistenza di allarme sanitario legato alla pandemia di coronavirus, da una forte ripresa economica negli Stati Uniti e in Europa grazie soprattutto alle graduali riaperture favorite dalle campagne di vaccinazioni. 

The 2015 Paris Agreement called for a 5-year cycle of updates on nationally determined contributions (NDC). This latest update would have occurred in 2020 but was postponed due to the COVID-19 pandemic.